Preclinical
For decades, the foundations of cancer treatment have been surgery, chemotherapy, and radiation therapy. However, these treatments are not always successful—hence, further research paved the way for immunotherapy, specifically, Chimeric Antigen Receptor (CAR) T-cell therapy. How CAR T-cell therapies work CAR T-cell therapy has been a huge area of research for over a decade, but...
Recently, there have been published reports stating that a large proportion of studies published in high-impact scientific journals could not be...
A sound preclinical plan coupled with expert oncology guidance can help identify biomarkers that can assist with patient selection—or help...
Too often, new drugs fail during development due to poor study design and inadequate knowledge about the performance of a new drug. A large part of...
If you’re exploring nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH) or cancer-associated liver fibrosis, you may want...
Ketogenic diets—which involve higher saturated fat, moderate protein and low carbohydrate consumption—have been successfully used to manage human...
